Small trial conducted by Stanford researchers links activity in the brain's reward processing system with drug relapse in patient cohort.
Young people prescribed opioids by dental providers were at increased risk of developing opioid addiction in the following year, a Stanford study found.
An anti-smoking ad campaign featuring a woman with depression helps smokers with mental health conditions attempt to quit.
During a talk at Stanford, journalist and author Barry Meier discussed his nearly two-decade long investigation into OxyContin and Purdue Pharma.
A recent NOVA episode focused on our country's addiction problem and highlighted the work of numerous researchers.
A team of economists have examined the importance of location and opioid prevalence to help tease out the relative importance of supply in the epidemic.
New Stanford research shows alarming trends in teens' use of a popular vaping device, suggesting they need better education about its addictive potential.
Stanford pain specialist argues for comprehensive and personalized treatments as Congress considers legislation to combat the opioid crisis.
Following surgery, the risk of overdose from opioids is highest during the first month. Taking both short- and long-acting opioids also boosts the risk.
Ketamine, a promising new treatment for depression, works through the brain's opioid system, Stanford study finds, defying long held beliefs.
Even substantial efforts in reducing opioid addiction, preventing overdoses and providing addiction treatment won't curb the crisis any time soon.
Stanford researchers examine the use of deep brain stimulation therapy to treat alcohol use disorders and reduce relapse rates.
In a JAMA opinion piece, Gary Peltz and Tom Sudhof argue for policymakers and health leaders to combat opioid addictions early.
After his daughter died of a drug overdose, George Ting established the Esther Ting Memorial Professorship in Addiction Medicine at Stanford.
Years into the opioid epidemic, Stanford psychiatrist and addiction researcher Anna Lembke cites signs of slow improvement and comments on benzodiazepines.
Stanford pain expert Beth Darnall discusses her clinical trials on methods to taper opioid doses for patients with chronic pain.